Announced 3.5 years ago, NIPER remains on paper
Nagpur: The local pharma fraternity had erupted in joy when Union minister Arun Jaitley announced setting up of National Institute of Pharmaceutical Education and Research (NIPER) in the city on…
Fear of side-effects, higher cost of medicine hampering treatment
KOCHI: Almost 30% of patients with diabetes make combined use of alternative medicines in state. Only 61% stick exclusively to modern medicine and 9% use only alternative medicine. The main…
Pharmacy gets shot in arm
AHMEDABAD: The state being hub of pharmaceutical industry, it does not come as a surprise that the majority of 5,000-odd seats for the Bachelor of Pharmacy (BPharm) were filled for…
Novartis gets European approval for sight therapy Luxturna
ZURICH: Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease. Luxturna is a one-time…
Lupin launches first chatbot for patients to know about their ailments
BENGALURU: Pharma major Lupin launched a chatbot named ‘ANYA’ designed to provide medically verified information for health-related queries. The disease awareness bot aims to answer patient queries related to ailments.…
Dr. Reddy’s shares spike after favourable generic drug ruling
Shares of Indian drugmaker Dr. Reddy’s Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell…
Zydus Cadila gets USFDA nod for generic cholesterol drug
New Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug Atorvastatin Calcium tablets. The Ahmedabad-based group has received final…
Glenmark gets USFDA nod for pneumonia treatment drug
New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of pneumonia. Glenmark Pharmaceuticals…
Indoco Remedies gets two minor observations from USFDA for Goa plants
New Delhi: Drug firm Indoco Remedies Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants. The US Food and Drug Administration…
Strides board approves USD 15 mn investment in Stelis Biopharma
New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The company’s board has approved participation…
